1. SelectQuote is under investigation for alleged illegal payments from insurers. 2. Claims suggest illegal payments over $80 million from Humana and Aetna from 2016-2021. 3. Senior officers may have been personally involved in the alleged scheme. 4. SelectQuote's shares dropped approximately 20% following the allegations' public disclosure. 5. Investigation includes possible breaches of fiduciary duties by the board.
Historical instances show similar allegations can severely impact stock value. Companies often suffer long-term reputational damage from legal issues.
The ongoing investigation into illegal payments directly threatens trust and value in SLQT.
Initial negative sentiment is likely, with potential for further declines till resolution. Similar cases have taken months for clarity.
BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. ("SelectQuote") (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers.
About the Investigation
Allegations that SelectQuote received illegal payments and other claims were unsealed in May 2025 after the U.S. Attorney's Office for the District of Massachusetts intervened to join claims pending in the District of Massachusetts first raised by a whistleblower. The complaint alleges that between 2016 and 2021, SelectQuote received illegal payments in the tens of millions of dollars—possibly amounting to more than 80 million dollars—from insurance carriers Humana and Aetna so that SelectQuote would steer insurance customers into Medicare offerings from Humana or Aetna. The complaint further alleges that the most senior officers of SelectQuote were personally involved in the scheme. Shares of SelectQuote subsequently declined approximately 20% upon the filing of the Department of Justice's complaint.
Berman Tabacco is investigating whether SelectQuote's board of directors had a role in this scheme and whether its officers and/or directors breached their fiduciary duties.
Contact
If you would like more information concerning our investigation, please contact us here: SelectQuote, Inc. | Berman Tabacco or at 800-516-9926 or at law@bermantabacco.com.
About Berman Tabacco
Since 1982, our firm has prosecuted hundreds of securities cases on behalf of investors. The firm and its attorneys have been recognized for their work on behalf of plaintiffs, including by Benchmark Litigation, which ranked the firm as a Top Plaintiffs' Firm and as Highly Recommended. Chambers USA recognized the firm as a leading securities litigation firm in its Securities Litigation–Mainly Plaintiff category. The Legal 500 has also ranked the firm as recommended in securities litigation. The firm has offices in Boston, Massachusetts and San Francisco, California.
This Notice May Constitute Attorney Advertising.
Past Results Do Not Guarantee Future Outcomes.
Quentin J. Morgan, Esq.
Berman Tabacco
One Liberty Square
Boston, Massachusetts
(800) 516-9926
Email: law@bermantabacco.com
